Song et al. demonstrated that CXCL12 increases pericyte motility in vitro and in a tumor xenograft model in vivo (Song et al., 2009), suggesting that pericytes express CXCR4 that facilitates their recruitment to endothelial cells (Virgintino et al., 2013). Here, CXCR4 is linked to neoplasm.